Białystok PLUS - Polish Longitudinal University Study
Launched by MEDICAL UNIVERSITY OF BIALYSTOK · Jun 20, 2017
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
One of the objectives of this project is to obtain comprehensive information on the health status (including subclinical disorders), genomics, risk factors, health behavior and sociodemographic data from large, representative sample of population of Białystok city inhabitants.
The study will assess many systems, the major emphasis will be given to the most common diseases associated with modern lifestyle (civilization diseases): cardiovascular, metabolic and endocrine, neurodegenerative, neoplastic and pulmonary. There are many interactions between them that might be missed when not analyz...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • inhabitants of Bialystok (randomly selected from the registry of Bialystok inhabitants)
- • age 20-80
- Exclusion Criteria:
- • disagreement of the invited person
About Medical University Of Bialystok
The Medical University of Bialystok is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to excellence in medical education and research, the university fosters collaboration among multidisciplinary teams to explore new therapeutic approaches and improve patient outcomes. With state-of-the-art facilities and a focus on translational medicine, the Medical University of Bialystok plays a pivotal role in the development of cutting-edge treatments and contributes significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Białystok, , Poland
Patients applied
Trial Officials
Karol A. Kaminski, Professor
Principal Investigator
Medical University of Bialystok
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials